ArticleAlimentary pharmacology & therapeutics2022

Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' reply.

Vivek C Goodoory et al.PubMed ↗Publisher ↗

No numbers read from the abstract.